Scheurer, M. E., Zhou, R., Gilbert, M. R., Bondy, M. L., Sulman, E. P., Yuan, Y., . . . Armstrong, T. (2015). EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825. Neuro Oncol.
Citação norma ChicagoScheurer, Michael E., et al. "EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825." Neuro Oncol 2015.
MLA CitationScheurer, Michael E., et al. "EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825." Neuro Oncol 2015.